Short Interest in Helius Medical Technologies, Inc. (NASDAQ:HSDT) Rises By 192.7%
Short Interest in Helius Medical Technologies, Inc. (NASDAQ:HSDT) Rises By 192.7%
Helius Medical Technologies, Inc. (NASDAQ:HSDT – Get Rating) was the recipient of a large growth in short interest in the month of July. As of July 31st, there was short interest totalling 173,600 shares, a growth of 192.7% from the July 15th total of 59,300 shares. Based on an average daily trading volume, of 2,350,000 shares, the short-interest ratio is presently 0.1 days.
和力士医疗技术公司(纳斯达克:HSDT-GET评级)是7月份空头股数大幅增长的接受者。截至7月31日,空头股数共有173,600股,比7月15日的59,300股增长了192.7%。以日均成交量2,350,000股计算,目前短息比为0.1天。
Institutional Inflows and Outflows
机构资金流入和流出
A number of hedge funds have recently modified their holdings of HSDT. Altium Capital Management LP bought a new position in shares of Helius Medical Technologies in the fourth quarter worth $254,000. Kepos Capital LP boosted its stake in Helius Medical Technologies by 296.4% in the fourth quarter. Kepos Capital LP now owns 100,304 shares of the company's stock valued at $521,000 after buying an additional 75,000 shares in the last quarter. Finally, AIGH Capital Management LLC acquired a new stake in Helius Medical Technologies in the fourth quarter valued at about $1,298,000. Institutional investors own 29.74% of the company's stock.
多家对冲基金最近调整了对HSDT的持股。Altium Capital Management LP在第四季度购买了Helius Medical Technologies价值25.4万美元的新头寸。Kepos Capital LP在第四季度将其在Helius Medical Technologies的持股增加了296.4%。Kepos Capital LP现在拥有100,304股该公司股票,价值521,000美元,上个季度又购买了75,000股。最后,AIGH Capital Management LLC在第四季度收购了Helius Medical Technologies的新股份,价值约1,298,000美元。机构投资者持有该公司29.74%的股票。
Helius Medical Technologies Stock Performance
Helius医疗技术公司股票表现
Shares of NASDAQ HSDT opened at $0.51 on Thursday. Helius Medical Technologies has a 52 week low of $0.45 and a 52 week high of $15.68. The stock has a market capitalization of $1.94 million, a P/E ratio of -0.07 and a beta of 0.72. The stock's fifty day moving average is $1.33 and its 200 day moving average is $2.52.
周四,新浪纳斯达克的股价开盘报0.51美元。Helius Medical Technologies的52周低点为0.45美元,52周高点为15.68美元。该股市值为194万美元,市盈率为-0.07,贝塔系数为0.72。该股的50日移动均线切入位为1.33美元,200日移动均线切入位为2.52美元。
About Helius Medical Technologies
关于Helius医疗技术公司
(Get Rating)
(获取评级)
Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.
Helius医疗技术公司是一家神经技术公司,专注于开发、许可和获取非侵入性技术,用于治疗神经疾病或创伤引起的症状。其产品便携式神经调节刺激器(PONS)是一种非手术医疗设备,旨在用于短期治疗因多发性硬化症症状而导致的步态缺陷和因轻至中度创伤性脑损伤而导致的平衡障碍,以及与有监督的治疗锻炼一起使用。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on Helius Medical Technologies (HSDT)
- Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
- The 2 Dow Stocks with Decade-Long Win Streaks on the Line
- Could Rite Aid Be an Acquisition Target, Again?
- The How And Why of Investing in Oil Stocks
- The How and Why of Investing in Gold Stocks
- 免费获取StockNews.com关于Helius医疗技术(HSDT)的研究报告
- 大型和小型石油和天然气类股盈利后反弹
- 连续十年上涨的两只道指股票
- Rite Aid会再次成为收购目标吗?
- 投资石油股票的方式和原因
- 投资黄金股票的方式和原因
Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
接受《赫利乌斯医疗技术日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Helius医疗技术公司和相关公司的最新新闻和分析师评级的每日简要摘要。